 Connection
Jason Glanz to Safety
This is a "connection" page, showing publications Jason Glanz has written about Safety.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.094 |
|
|
|
-
Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample. Biom J. 2018 07; 60(4):748-760.
Score: 0.472
-
Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25.
Score: 0.349
-
Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29.
Score: 0.101
-
Glanz JM, Kraus CR, Daley MF. Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing. PLoS Biol. 2015 Aug; 13(8):e1002227.
Score: 0.097
-
Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):749-55.
Score: 0.074
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|